Compound Detail
CHEMBL59356
ATRELEUTON 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL59356 |
| Name | ATRELEUTON |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | MMSNEKOTSJRTRI-LLVKDONJSA-N |
5
Targets
9
Activities
1
Assay Types
8
PK Parameters
20
Publications
6
Known Names
3
Indications
1
Mechanisms
Molecular Properties
318.4
MW (Da)
2.99
ALogP
3
HBA
2
HBD
66.6
PSA (Ų)
0.52
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Arachidonate 5-lipoxygenase inhibitor | INHIBITOR | Polyunsaturated fatty acid 5-lipoxygenase | ✓ | ✓ |
Indications
Acute Coronary Syndrome Atherosclerosis Coronary Disease
Activity Summary
IC50 9 meas. best 7.64
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Polyunsaturated fatty acid 5-lipoxygenase CHEMBL312 | IC50 | 7.64 | 7.64 | 23.0 | 1 |
| Homo sapiens CHEMBL372 | IC50 | 7.64 | 7.23 | 23.0 | 2 |
| RBL-1 CHEMBL614772 | IC50 | 7.64 | 7.64 | 23.0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase CHEMBL215 | IC50 | 7.05 | 6.8625 | 90.0 | 4 |
| Bifunctional epoxide hydrolase 2 CHEMBL2409 | IC50 | 5.57 | 5.57 | 2700.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 3.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| F | 60.0 | % | Rattus norvegicus |
| F | 100.0 | % | Mus musculus |
| F | 90.0 | % | Cavia porcellus |
| F | 95.0 | % | Canis lupus familiaris |
| F | 90.0 | % | Macaca fascicularis |
| T1/2 | 15.0 | hr | - |
| T1/2 | 15.0 | hr | Simiiformes |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine